Palmitoylethanolamide (PEA) as it relates to the Endocannabinoid System

Palmitoylethanolamide (PEA) as it relates to the Endocannabinoid System

Recently Palmitoylethanolamide (PEA) is being talked about more often in the cannabis and hemp industry. It is emerging as a noteworthy compound, intricately linked with the endocannabinoid system (ECS).

What is PEA? It’s a naturally occurring fatty acid amide and plays a pivotal role in our body's internal management of pain and inflammation.

But how does PEA interact with the ECS, and why is this important?

Unlike direct activators of cannabinoid receptors, PEA enhances the ECS's functionality through an "entourage effect," modulating pain and inflammatory responses without directly binding to cannabinoid receptors. This mechanism of action offers a promising pathway for managing chronic pain, inflammation, and even neurological conditions, with minimal side effects.

Health Benefits of PEA:

  • Pain Relief: PEA has been shown to reduce chronic and neuropathic pain, offering a natural alternative to traditional painkillers
  • Anti-inflammatory: Its anti-inflammatory properties make it a candidate for managing conditions like arthritis and fibromyalgia.
  • Neuroprotection: Potential benefits in neurodegenerative diseases due to its neuroprotective effects.

Here’s a more detailed breakdown:

Pain Relief: A meta-analysis exploring the efficacy of PEA for treating pain demonstrated that PEA was associated with significantly greater pain reduction compared to inactive control conditions across several studies. This analysis included data from 786 patients who received PEA and 512 controls, indicating PEA's potential as a useful treatment for pain. The study also highlighted the general tolerability of PEA in research populations, suggesting further research could help provide reliable estimates of its efficacy​​.
Source: https://pubmed.ncbi.nlm.nih.gov/28727699/

Anti-inflammatory Properties: The anti-inflammatory effects of PEA are well-documented, with studies showing its effectiveness in managing chronic pain through modulation of mast cells and microglia activation. This action not only contributes to pain relief but also to the reduction of inflammation, making it a candidate for managing conditions such as arthritis and fibromyalgia​​.
Source: https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-018-0934-z

Neuroprotection: PEA's neuroprotective effects are linked to its ability to modulate various cellular processes, including those involved in neuroinflammation and neurotoxicity. Research suggests that PEA can have beneficial effects on signaling pathways implicated in the development of spinal cord injury and may support the release of neurotrophic factors after such injuries. This indicates a potential for PEA in the treatment and management of neurodegenerative diseases through its neuroprotective mechanisms.
Source:  https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-018-0934-z

Discover the power of PEA in Resynate’s Pain Relief Tablets:  A natural alternative to traditional forms of pain management. CBD, CBDa, and terpenes work in combination with PEA (palmitoylethanolamide), antioxidants, and curcumin (turmeric) to potentially reduce both acute and chronic pain and inflammation in the body without the possible side effects of medications.


Leave a comment

Please note, comments must be approved before they are published

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.